PMDA drug package insert
ゼプリオン水懸筋注25mgシリンジ
PMDA Prescription drug · ヤンセンファーマ株式会社 · package insert Dec 12, 2025
Key facts
| Brand names | ゼプリオン水懸筋注25mgシリンジ, ゼプリオン水懸筋注50mgシリンジ, ゼプリオン水懸筋注75mgシリンジ, ゼプリオン水懸筋注100mgシリンジ, ゼプリオン水懸筋注150mgシリンジ |
|---|---|
| Nonproprietary names | パリペリドンパルミチン酸エステル |
| Companies | 製造販売元（輸入）／ヤンセンファーマ株式会社, 発売元／住友ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持効性抗精神病剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179409G1025, 1179409G2021, 1179409G3028, 1179409G4024, 1179409G5020 |
| Approval numbers | 22500AMX01791000, 22500AMX01792000, 22500AMX01793000, 22500AMX01794000, 22500AMX01795000 |
| Package insert edition | 第6版 |
| Package insert date | Dec 12, 2025 |
| PMDA document key | 800155_1179409G1025_1 |
| PMDA company code | 800155 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: